AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11159256 — intervention group
Group type: EXPERIMENTAL
Intervention: Sustained-release morphine 90 mg/d
Number of subjects: 43
Study 11159256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 9013163 — intervention group
Group type: EXPERIMENTAL
Intervention: 60% nitrous oxide
Number of subjects: 38
Study 9013163 — intervention group
Group type: COMPARATOR
Intervention: Oxygen (placebo control)
Number of subjects: 38
Study 7880656 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 0.8% glucose
Number of subjects: 80
Study 7880656 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine with 0% glucose
Number of subjects: 80
Study 7880656 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 0.8% glucose at L2-3 interspace
Number of subjects: 80
Study 7880656 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine with 8% glucose
Number of subjects: 80
Study 2516615 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorbiphos (2 g)
Number of subjects: 5
Study 2516615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study 2516615 — intervention group
Group type: EXPERIMENTAL
Intervention: Alu-Cap (950 mg)
Number of subjects: 5
Study 787738 — intervention group
Group type: EXPERIMENTAL
Intervention: Mersyndol (analgesic/antihistamine combination containing paracetamol, codeine phosphate, doxylamine succinate, and caffeine)
Number of subjects: 0
Study 787738 — intervention group
Group type: EXPERIMENTAL
Intervention: Mersyndol (analgesic/antihistamine combination)
Number of subjects: 0
Study 787738 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31803945 — intervention group
Group type: COMPARATOR
Intervention: SBIRT-only
Number of subjects: 181
Study 31803945 — intervention group
Group type: EXPERIMENTAL
Intervention: SBIRT + Alcohol Treatment
Number of subjects: 181
Study 31711088 — intervention group
Group type: EXPERIMENTAL
Intervention: Implants placed in surgically bone-grafted sites
Number of subjects: 304
Study 31711088 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of adjacent implants
Number of subjects: 304
Study 31711088 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall implants
Number of subjects: 304
Study 28246207 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI/simtuzumab 700 mg
Number of subjects: 249
Study 28246207 — intervention group
Group type: EXPERIMENTAL
Intervention: FOLFIRI/simtuzumab 200 mg
Number of subjects: 249
Study 28246207 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI/placebo
Number of subjects: 249
Study 25294746 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle change (ILS)
Number of subjects: 382
Study 25294746 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 382
Study 25294746 — intervention group
Group type: COMPARATOR
Intervention: Metformin 850 mg twice a day
Number of subjects: 382
Study 23791258 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA Fillapex
Number of subjects: 45
Study 23791258 — intervention group
Group type: EXPERIMENTAL
Intervention: MTA Plus
Number of subjects: 45
Study 23791258 — intervention group
Group type: COMPARATOR
Intervention: AH Plus (Control)
Number of subjects: 45
Study 21240170 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine 1ml/kg (Group I)
Number of subjects: 60
Study 21240170 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% bupivacaine 1ml/kg with clonidine 2μg/kg (Group II)
Number of subjects: 60
Study 21240170 — intervention group
Group type: COMPARATOR
Intervention: Control group (Group I)
Number of subjects: 60
Study 19856686 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium
Number of subjects: 119
Study 19856686 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium
Number of subjects: 119
Study 19856686 — intervention group
Group type: COMPARATOR
Intervention: Fluid replacement therapy
Number of subjects: 119
Study 17053946 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave treatment after open reduction and internal fixation
Number of subjects: 56
Study 17053946 — intervention group
Group type: COMPARATOR
Intervention: Control group (open reduction and internal fixation without shockwave treatment)
Number of subjects: 56
Study 17053946 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave treatment
Number of subjects: 56
Study 14971537 — intervention group
Group type: EXPERIMENTAL
Intervention: Meshed skin graft method (expansion ratio 1:3)
Number of subjects: 80
Study 14971537 — intervention group
Group type: COMPARATOR
Intervention: Split thickness skin graft method
Number of subjects: 80
Study 14971537 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 10916098 — intervention group
Group type: EXPERIMENTAL
Intervention: HCTZ (50 mg) + KHCO3 (60 mmol daily)
Number of subjects: 50
Study 10916098 — intervention group
Group type: COMPARATOR
Intervention: HCTZ (50 mg) + KCl (60 mmol daily)
Number of subjects: 50
Study 10916098 — intervention group
Group type: COMPARATOR
Intervention: KHCO3 (60 mmol daily) alone
Number of subjects: 50
Study 9238885 — intervention group
Group type: EXPERIMENTAL
Intervention: Rowenta Dentiphant powered toothbrush
Number of subjects: 0
Study 9238885 — intervention group
Group type: COMPARATOR
Intervention: Oral-B 20 toothbrush
Number of subjects: 0
Study 1431574 — intervention group
Group type: EXPERIMENTAL
Intervention: Monounsaturated fatty acid diet (n = 29)
Number of subjects: 173
Study 1431574 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyunsaturated fatty acid diet (n = 29)
Number of subjects: 173
Study 1431574 — intervention group
Group type: EXPERIMENTAL
Intervention: Oleic acid diet
Number of subjects: 173
Study 1431574 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-fatty acid diet
Number of subjects: 173
Study 1431574 — intervention group
Group type: EXPERIMENTAL
Intervention: Stearic acid diet
Number of subjects: 173
Study 1431574 — intervention group
Group type: EXPERIMENTAL
Intervention: Linoleic acid diet
Number of subjects: 173
Study 1431574 — intervention group
Group type: EXPERIMENTAL
Intervention: Trans-monounsaturates diet
Number of subjects: 173
Study 6143514 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromazepam
Number of subjects: 0
Study 6143514 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 0
Study 30672800 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenalectomy for unilateral primary aldosteronism
Number of subjects: 380
Study 30672800 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive score based on six presurgical factors
Number of subjects: 380
Study 30759696 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderately hypofractionated radiation therapy (240-340 cGy per fraction)
Number of subjects: 0
Study 30759696 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrahypofractionated radiation therapy (500 cGy or more per fraction)
Number of subjects: 0
Study 30759696 — intervention group
Group type: COMPARATOR
Intervention: Ultrahypofractionated external beam radiation therapy
Number of subjects: 0
Study 30759696 — intervention group
Group type: EXPERIMENTAL
Intervention: Image guided radiation therapy
Number of subjects: 0
Study 30759696 — intervention group
Group type: COMPARATOR
Intervention: Nonmodulated 3-dimensional conformal techniques
Number of subjects: 0
Study 28971842 — intervention group
Group type: EXPERIMENTAL
Intervention: Beetroot powder containing inorganic nitrate (BRA)
Number of subjects: 13
Study 28971842 — intervention group
Group type: COMPARATOR
Intervention: Placebo (beetroot powder devoid of inorganic nitrate, BRP)
Number of subjects: 13
Study 27711118 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-on practical workshop
Number of subjects: 0
Study 27711118 — intervention group
Group type: COMPARATOR
Intervention: Discussion or lecture
Number of subjects: 0
Study 24267728 — intervention group
Group type: EXPERIMENTAL
Intervention: Emollient combining glycerol and paraffin
Number of subjects: 251
Study 24267728 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 251
Study 22917200 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 279
Study 22917200 — intervention group
Group type: EXPERIMENTAL
Intervention: Older age and less severe ADHD symptoms
Number of subjects: 279
Study 19545360 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard intact cow milk protein formula (INTACT)
Number of subjects: 335
Study 19545360 — intervention group
Group type: COMPARATOR
Intervention: Partially hydrolyzed cow milk protein formula (PH)
Number of subjects: 335
Study 19545360 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall study discontinuance based on parent-assessed intolerance
Number of subjects: 335
Study 19545360 — intervention group
Group type: COMPARATOR
Intervention: Overall study discontinuance based on study physician-assessed intolerance
Number of subjects: 335
Study 17527035 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-iron diet for six months
Number of subjects: 40
Study 17527035 — intervention group
Group type: COMPARATOR
Intervention: Phlebotomy biweekly
Number of subjects: 40
Study 15170704 — intervention group
Group type: EXPERIMENTAL
Intervention: Eptifibatide (Integrilin)
Number of subjects: 300
Study 15170704 — intervention group
Group type: COMPARATOR
Intervention: Heparin only (Control)
Number of subjects: 300
Study 11673318 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual and motor evoked potentials (VEP and MEP)
Number of subjects: 30
Study 11673318 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined latencies of VEP and MEP using the sum of their Z scores
Number of subjects: 30
Study 11673318 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrophysiological data and EDSS changes over time
Number of subjects: 30
Study 11673318 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline VEP and MEP
Number of subjects: 30
Study 9638493 — intervention group
Group type: EXPERIMENTAL
Intervention: Transrectal ultrasonography
Number of subjects: 25
Study 9638493 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromyography and rectal sensitivity studies
Number of subjects: 25
Study 9638493 — intervention group
Group type: COMPARATOR
Intervention: Healthy subjects (control group)
Number of subjects: 25
Study 8088394 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol 200 mg orally at 24 h and 2 h preoperatively and again at 24 h postoperatively
Number of subjects: 29
Study 8088394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 8088394 — intervention group
Group type: EXPERIMENTAL
Intervention: Allopurinol
Number of subjects: 29
Study 2683005 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha human leukocyte interferon (IFN) ointment
Number of subjects: 0
Study 2683005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 1194512 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol (vodka and tonic)
Number of subjects: 96
Study 1194512 — intervention group
Group type: COMPARATOR
Intervention: Nonalcoholic beverage (tonic water)
Number of subjects: 96
Study 1194512 — intervention group
Group type: EXPERIMENTAL
Intervention: Provocation to aggress
Number of subjects: 96
Study 1194512 — intervention group
Group type: COMPARATOR
Intervention: Neutral interaction (control condition)
Number of subjects: 96
Study 30656549 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG (LGG) with cow's milk protein free diet
Number of subjects: 100
Study 30656549 — intervention group
Group type: COMPARATOR
Intervention: Placebo with milk-free diet
Number of subjects: 100
Study 31470798 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzalkonium chloride (BZK)
Number of subjects: 50
Study 31470798 — intervention group
Group type: COMPARATOR
Intervention: Povidone iodine (PVI)
Number of subjects: 50
Study 31470798 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro growth inhibitory activity
Number of subjects: 50
Study 27909881 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment message with pride emotional appeal
Number of subjects: 199
Study 27909881 — intervention group
Group type: EXPERIMENTAL
Intervention: Recruitment message with financial incentive
Number of subjects: 199
Study 27909881 — intervention group
Group type: COMPARATOR
Intervention: Other ad hoc messages
Number of subjects: 199
Study 26398912 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted total gastrectomy
Number of subjects: 753
Study 26398912 — intervention group
Group type: COMPARATOR
Intervention: Open total gastrectomy
Number of subjects: 753
Study 23511717 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional remediation
Number of subjects: 239
Study 23511717 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 239
Study 23511717 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 239
Study 21678716 — intervention group
Group type: EXPERIMENTAL
Intervention: six-week treatment regimen for type 1 diabetes
Number of subjects: 8
Study 21678716 — intervention group
Group type: EXPERIMENTAL
Intervention: self-reported questionnaires
Number of subjects: 8
Study 19284948 — intervention group
Group type: EXPERIMENTAL
Intervention: Changjishu soft elastic capsule (4 capsules once daily, 3 times a day)
Number of subjects: 104
Study 16702330 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified seasoning powder (zinc 5 mg, iron 5 mg, vitamin A 270 microg, iodine 50 microg) served with school lunch 5 days/week for 31 weeks
Number of subjects: 569
Study 16702330 — intervention group
Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified seasoning powder
Number of subjects: 569
Study 15277727 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone (Spi)
Number of subjects: 168
Study 15277727 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 168
Study 10837943 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (GS = 2-6, T1-2Nx)
Number of subjects: 1557
Study 10837943 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 (GS = 2-6, T3Nx; or GS = 2-6, N+; or GS = 7, T1-2Nx)
Number of subjects: 1557
Study 10837943 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 (T3Nx, GS = 7; or N+, GS = 7; or T1-2Nx, GS = 8-10)
Number of subjects: 1557
Study 10837943 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 4 (T3Nx, GS = 8-10; or N+, GS = 8-10)
Number of subjects: 1557
Study 9093172 — intervention group
Group type: EXPERIMENTAL
Intervention: Ispaghula (dietary fibre)
Number of subjects: 0
Study 9093172 — intervention group
Group type: COMPARATOR
Intervention: Standard preparation of bisacodyl
Number of subjects: 0
Study 1283191 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilvadipine
Number of subjects: 659
Study 1283191 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine
Number of subjects: 659
Study 1283191 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 659
Study 3963953 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride
Number of subjects: 28
Study 3963953 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline
Number of subjects: 28
Study 29181560 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-Specific Instrumentation (PSI)
Number of subjects: 42
Study 29181560 — intervention group
Group type: COMPARATOR
Intervention: Conventional Instrumentation (CI)
Number of subjects: 42
Study 25145587 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored self-efficacy intervention
Number of subjects: 97
Study 25145587 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 97
Study 25499943 — intervention group
Group type: EXPERIMENTAL
Intervention: Mipomersen therapy
Number of subjects: 7
Study 23600790 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaviscon Advance (GA)
Number of subjects: 20
Study 23600790 — intervention group
Group type: COMPARATOR
Intervention: Antacid (Milk of Magnesia)
Number of subjects: 20
Study 20870219 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety behavior use (SBU)
Number of subjects: 43
Study 20870219 — intervention group
Group type: COMPARATOR
Intervention: No safety behavior use (NSB)
Number of subjects: 43
Study 18258624 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet rich in n-3 PUFAs (3.5% of energy intake)
Number of subjects: 26
Study 18258624 — intervention group
Group type: COMPARATOR
Intervention: Control diet (0.5% of energy intake from n-3 PUFAs)
Number of subjects: 26
Study 17007162 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention 1
Number of subjects: 754
Study 17007162 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention 2
Number of subjects: 754
Study 17007162 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 754
Study 17007162 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including control)
Number of subjects: 754
Study 12748410 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegetarians
Number of subjects: 81
Study 12748410 — intervention group
Group type: EXPERIMENTAL
Intervention: Vegans
Number of subjects: 81
Study 12748410 — intervention group
Group type: COMPARATOR
Intervention: Mixed diet
Number of subjects: 81
Study 10910606 — intervention group
Group type: EXPERIMENTAL
Intervention: HBV-NF vaccine
Number of subjects: 116
Study 10910606 — intervention group
Group type: COMPARATOR
Intervention: Engerix-B vaccine
Number of subjects: 116
Study 10910606 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 116
Study 7722114 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol (3.125 mg twice a day, titrated to 6.25 to 25 mg twice a day for < 75 kg or 50 mg twice a day for > 75 kg)
Number of subjects: 60
Study 7722114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 2047947 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol 1,000 micrograms by inhalation
Number of subjects: 23
Study 2047947 — intervention group
Group type: COMPARATOR
Intervention: Salbutamol 200 micrograms by inhalation
Number of subjects: 23
Study 7358871 — intervention group
Group type: EXPERIMENTAL
Intervention: Morning scheduling (A.M.)
Number of subjects: 16
Study 7358871 — intervention group
Group type: EXPERIMENTAL
Intervention: Afternoon scheduling (P.M.)
Number of subjects: 16
Study 7358871 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall measures
Number of subjects: 16
Study 31483150 — intervention group
Group type: EXPERIMENTAL
Intervention: Jogging and foam-rolling exercises (8 minutes)
Number of subjects: 30
Study 31483150 — intervention group
Group type: COMPARATOR
Intervention: Jogging (8 minutes)
Number of subjects: 30
Study 28639346 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-calorie diet (1,250 kcal/d) for 12 weeks
Number of subjects: 16
Study 28639346 — intervention group
Group type: COMPARATOR
Intervention: Very-low-calorie diet (500 kcal/d) for 5 weeks followed by a 4-week weight-stable period
Number of subjects: 16
Study 28639346 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (DI) period
Number of subjects: 16
Study 25994838 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 20 mg once daily
Number of subjects: 2850
Study 25994838 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 10 mg once daily
Number of subjects: 2850
Study 25994838 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg daily
Number of subjects: 2850
Study 22707179 — intervention group
Group type: EXPERIMENTAL
Intervention: Dignity therapy (palliative care psychotherapy)
Number of subjects: 49
Study 22707179 — intervention group
Group type: EXPERIMENTAL
Intervention: Research participation (regardless of intervention)
Number of subjects: 49
Study 22078241 — intervention group
Group type: EXPERIMENTAL
Intervention: mDOT (directly observed daily ribavirin plus provider-administered weekly IFN)
Number of subjects: 80
Study 22078241 — intervention group
Group type: COMPARATOR
Intervention: TAU (self-administered ribavirin plus provider-administered weekly IFN)
Number of subjects: 80
Study 19735340 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic play intervention
Number of subjects: 203
Study 19735340 — intervention group
Group type: COMPARATOR
Intervention: Routine information preparation
Number of subjects: 203
Study 16402259 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory task in AD patients
Number of subjects: 30
Study 16402259 — intervention group
Group type: EXPERIMENTAL
Intervention: Working memory task in MCI patients
Number of subjects: 30
Study 16402259 — intervention group
Group type: COMPARATOR
Intervention: Working memory task in controls
Number of subjects: 30
Study 16402259 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of AD and MCI groups
Number of subjects: 30
Study 15157731 — intervention group
Group type: EXPERIMENTAL
Intervention: Earlier treatment of peripheral retina ablation
Number of subjects: 401
Study 15157731 — intervention group
Group type: COMPARATOR
Intervention: Conventional management of peripheral retina ablation
Number of subjects: 401
Study 15157731 — intervention group
Group type: EXPERIMENTAL
Intervention: Retinal structure assessment
Number of subjects: 401
Study 11782323 — intervention group
Group type: EXPERIMENTAL
Intervention: BIS group (isoflurane titrated to maintain BIS value between 50-60)
Number of subjects: 68
Study 11782323 — intervention group
Group type: COMPARATOR
Intervention: SP group (standard practice, anesthesiologists blinded to BIS value)
Number of subjects: 68
Study 9836158 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational handout about colposcopy mailed one week before appointment
Number of subjects: 113
Study 9836158 — intervention group
Group type: COMPARATOR
Intervention: No mailed handout (control group)
Number of subjects: 113
Study 7662924 — intervention group
Group type: EXPERIMENTAL
Intervention: The Circle of Life teaching strategy
Number of subjects: 43
Study 2719902 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (200 mg three times daily and 400 mg at night)
Number of subjects: 5
Study 944022 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose addition to electrolyte mixture
Number of subjects: 94
Study 944022 — intervention group
Group type: COMPARATOR
Intervention: Glucose addition to electrolyte mixture
Number of subjects: 94
Study 6175933 — intervention group
Group type: EXPERIMENTAL
Intervention: cis-diamminodichloroplatinum (II) plus Bleomycin
Number of subjects: 33
Study 6175933 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate and vindesine
Number of subjects: 33
Study 6175933 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary chemotherapy (pc)
Number of subjects: 33